Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · June 05, 2023

T-Cell Responses to COVID-19 Vaccination Despite Disease-Modifying Therapy for MS

JCI insight


Additional Info

Disclosure statements are available on the authors' profiles:

JCI insight
T cell responses to SARS-CoV-2 vaccination differ by disease-modifying therapy for multiple sclerosis
JCI Insight 2023 May 09;[EPub Ahead of Print], AS Wolf, A Ravussin, M König, MH Øverås, G Solum, IF Kjønstad, A Chopra, T Holmøy, HF Harbo, SW Syversen, KK Jørgensen, EA Høgestøl, JT Vaage, EG Celius, F Lund-Johansen, LA Munthe, GO Nygaard, S Mjaaland

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading